Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to -$507000.0.

  • Viemed Healthcare's Interest & Investment Income fell 12533.33% to -$507000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$965000.0, marking a year-over-year decrease of 903.95%. This contributed to the annual value of -$776000.0 for FY2024, which is 8301.89% down from last year.
  • Viemed Healthcare's Interest & Investment Income amounted to -$507000.0 in Q3 2025, which was down 12533.33% from -$132000.0 recorded in Q2 2025.
  • Over the past 5 years, Viemed Healthcare's Interest & Investment Income peaked at $49000.0 during Q1 2023, and registered a low of -$507000.0 during Q3 2025.
  • Its 5-year average for Interest & Investment Income is -$133315.8, with a median of -$91000.0 in 2021.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 17656.25% in 2023, then crashed by 137000.0% in 2024.
  • Viemed Healthcare's Interest & Investment Income (Quarter) stood at -$69000.0 in 2021, then skyrocketed by 53.62% to -$32000.0 in 2022, then tumbled by 700.0% to -$256000.0 in 2023, then surged by 42.58% to -$147000.0 in 2024, then tumbled by 244.9% to -$507000.0 in 2025.
  • Its last three reported values are -$507000.0 in Q3 2025, -$132000.0 for Q2 2025, and -$179000.0 during Q1 2025.